Walgreens Boots Alliance Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Walgreens Boots Alliance wird ein jährliches Gewinn- und Umsatzwachstum von 98.4% bzw. 1.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 108.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13.1% betragen.
Wichtige Informationen
98.4%
Wachstumsrate der Gewinne
108.6%
EPS-Wachstumsrate
| Consumer Retailing Gewinnwachstum | 12.1% |
| Wachstumsrate der Einnahmen | 1.5% |
| Zukünftige Eigenkapitalrendite | 13.1% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 13 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Walgreens Q4: 2 Signs Of A Dividend Trap
Oct 29Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential
Oct 23Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Oct 17
Walgreens: A Turnaround Stock To Avoid
Oct 15Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying
Sep 29Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?
Sep 09Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses
Sep 06Is Walgreens Ready To Rebound?
Aug 23Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play
Aug 13Walgreens: A Painful Turnaround Lesson
Aug 02Walgreens: Here's What Comes Next
Jul 09Walgreens: Yielding Over 8% Following The Earnings Drop
Jul 02Walgreens: Beware The Value Trap Ahead Of Earnings
Jun 24Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)
May 305 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows
May 22Walgreens: Hold Tight, Let It Turn Around First
May 06Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky
May 053 Reasons Walgreens Can See Upside (Rating Upgrade)
Apr 10Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
Apr 08Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed
Apr 04Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem
Mar 27Walgreens' Strategic Pivot
Mar 21Walgreens Q2, Dow Exit, And Bet Against Wall Street
Mar 15Walgreens: New CEO Looking To Right The Ship
Feb 13Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky
Jan 19Walgreens Boots Alliance: Income Opportunity After Dividend Cut
Jan 17Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)
Jan 10After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar
Dec 24Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48
Oct 31Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet
Oct 02Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 8/31/2027 | 153,887 | 278 | 1,347 | 2,392 | 6 |
| 8/31/2026 | 151,682 | 198 | 928 | 2,165 | 15 |
| 8/31/2025 | 148,933 | -468 | -354 | 1,124 | 16 |
| 8/31/2024 | 147,658 | -8,636 | -363 | 1,018 | N/A |
| 5/31/2024 | 145,533 | -5,811 | -894 | 725 | N/A |
| 2/29/2024 | 144,597 | -6,037 | -1,766 | 101 | N/A |
| 11/30/2023 | 142,406 | 574 | -529 | 1,484 | N/A |
| 8/31/2023 | 139,081 | -3,080 | 141 | 2,258 | N/A |
| 5/31/2023 | 136,108 | -3,315 | -821 | 1,305 | N/A |
| 2/28/2023 | 133,291 | -3,144 | 982 | 2,954 | N/A |
| 11/30/2022 | 132,184 | -2,964 | 1,403 | 3,293 | N/A |
| 8/31/2022 | 132,703 | 4,337 | 2,165 | 3,899 | N/A |
| 5/31/2022 | 134,516 | 5,111 | 3,439 | 5,058 | N/A |
| 2/28/2022 | 135,948 | 5,926 | 3,626 | 5,183 | N/A |
| 11/30/2021 | 134,972 | 5,965 | 4,057 | 5,459 | N/A |
| 8/31/2021 | 132,509 | 1,994 | 4,176 | 5,555 | N/A |
| 5/31/2021 | 128,617 | 1,972 | 4,983 | 6,396 | N/A |
| 2/28/2021 | 124,952 | -926 | 4,195 | 5,556 | N/A |
| 11/30/2020 | 123,509 | -981 | 4,200 | 5,618 | N/A |
| 8/31/2020 | 121,982 | 179 | 4,110 | 5,484 | N/A |
| 5/31/2020 | 125,566 | 519 | 4,359 | 5,777 | N/A |
| 2/29/2020 | 129,792 | 3,339 | 5,269 | 6,883 | N/A |
| 11/30/2019 | 132,984 | 3,628 | 4,576 | 6,195 | N/A |
| 8/31/2019 | 120,074 | 3,816 | 3,892 | 5,594 | N/A |
| 5/31/2019 | 136,354 | 4,817 | 4,402 | 6,032 | N/A |
| 2/28/2019 | 136,097 | 5,133 | 4,756 | 6,250 | N/A |
| 11/30/2018 | 134,590 | 5,326 | 6,261 | 7,720 | N/A |
| 8/31/2018 | 131,537 | 5,024 | 6,896 | 8,263 | N/A |
| 5/31/2018 | 128,244 | 4,314 | N/A | 7,460 | N/A |
| 2/28/2018 | 124,028 | 4,134 | N/A | 7,077 | N/A |
| 11/30/2017 | 120,453 | 3,845 | N/A | 7,729 | N/A |
| 8/31/2017 | 118,214 | 4,078 | N/A | 7,255 | N/A |
| 5/31/2017 | 116,701 | 4,306 | N/A | 7,895 | N/A |
| 2/28/2017 | 116,081 | 4,247 | N/A | 8,144 | N/A |
| 11/30/2016 | 116,819 | 4,117 | N/A | 7,640 | N/A |
| 8/31/2016 | 117,351 | 4,173 | N/A | 7,847 | N/A |
| 5/31/2016 | 117,237 | 3,169 | N/A | 6,694 | N/A |
| 2/29/2016 | 116,534 | 3,368 | N/A | 6,412 | N/A |
| 11/30/2015 | 112,923 | 4,480 | N/A | 5,365 | N/A |
| 8/31/2015 | 103,444 | 4,220 | N/A | 5,664 | N/A |
| 5/31/2015 | 93,979 | 3,973 | N/A | 5,543 | N/A |
| 2/28/2015 | 84,585 | 3,385 | N/A | 4,993 | N/A |
| 11/30/2014 | 77,617 | 2,059 | N/A | 4,791 | N/A |
| 8/31/2014 | 76,392 | 1,932 | N/A | 3,893 | N/A |
| 5/31/2014 | 75,276 | 2,810 | N/A | 3,632 | N/A |
| 2/28/2014 | 74,188 | 2,720 | N/A | 3,739 | N/A |
| 11/30/2013 | 73,230 | 2,760 | N/A | 3,833 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: WBA wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.6%).
Ertrag vs. Markt: WBA wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: WBA wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: WBADie Einnahmen des Unternehmens (1.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).
Hohe Wachstumseinnahmen: WBADie Einnahmen des Unternehmens (1.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: WBADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13.1%).